Corcept Therapeutics Inc (NASDAQ:CORT)

22.25
Delayed Data
As of Dec 06
 +1.34 / +6.41%
Today’s Change
17.57
Today|||52-Week Range
31.18
-14.95%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$2.5B

Company Description

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development and commercialization of medications to treat severe metabolic, oncologic and psychiatric disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.

Contact Information

Corcept Therapeutics, Inc.
149 Commonwealth Drive
Menlo Park California 94025
P:(650) 327-3270
Investor Relations:
(650) 684-7054

Employees

Shareholders

Mutual fund holders38.26%
Other institutional32.22%
Individual stakeholders31.87%

Top Executives

Joseph K. BelanoffPresident, Chief Executive Officer & Director
Atabak MokariChief Financial Officer
Hazel HuntChief Scientific Officer
Sean MaduckChief Commercial Officer
William GuyerChief Development Officer